siRNA, Anti-CCDC144A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT31231WQ-2OMe)
The product SIRGT31231WQ-2OMe is a type of small interfering RNA (siRNA) that targets CCDC144A gene and regulates the expression of gene. The siRNA interferes with the expression of CCDC144A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_014695.2 |
| Related Diseases | Smith-Magenis Syndrome |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT32231WQ-2F | CCDC144A | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT33231WQ-2MOE | CCDC144A | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT34231WQ-LNA | CCDC144A | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT31231WQ-RB | CCDC144A | Human | Ribo-modified | ||
| SIRGT32231WQ-BB | CCDC144A | Human | Backbone-modified |